Tumour necrosis factor-α gene polymorphisms in asbestos-induced diseases

Biomarkers

Volumn 15, Issue 5, 2010, Pages 400-409

  Helmig, Simone ^a   Aliahmadi, Nahid ^a   Schneider, Joachim ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Asbestos; Cytokines; Lung cancer; Lung fibrosis; Single nucleotide polymorphisms; TNF gene polymorphism

Indexed keywords

ASBESTOS; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASBESTOSIS; CANCER PATIENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GERMANY; HUMAN; LUNG CARCINOMA; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ASBESTOS; CARCINOGENS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PULMONARY FIBROSIS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77954859839     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.481365     Document Type: Article

References (51)

1. ATS/ERS. (2000). Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med, 161, 646-664
2. ATS/ERS. (2002). American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277-304.
3. Abraham LJ, Kroeger KM. (1999). Impact of the-308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66:562-566
4. Ates I, Suzen HS, Yucesoy B, Tekin IO, Karakaya A. (2008). Association of cytokine gene polymorphisms in CWP and its severity in Turkish coal workers. Am J Ind Med 51:741-747
5. Ates I, Yucesoy B, Yucel A, Suzen SH, Karakas Y, Karakaya A. (2009). Possible effect of gene polymorphisms on the release of TNFalpha and IL1 cytokines in coal workers' pneumoconiosis. Exp Toxicol Pathol [Epub ahead of print].
6. Balkwill, F. (2006). TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev 25:409-416
7. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, Mcdermott MF, Oksenberg J, Mcnicholl J, Pociot F, Hardt C, D'Alfonso S. (1999). Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1:3-19.
8. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, Mcdermott MF, Oksenberg J, Mcnicholl J, Pociot F, Hardt C, D'Alfonso S. (2001). Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun 2:61-70.
9. Corbett EL, Mozzato-Chamay N, Butterworth AE, De Cock KM, Williams BG, Churchyard GJ, Conway DJ. (2002). Polymorphisms in the tumor necrosis factor-alpha gene promoter may predispose to severe silicosis in black South African miners. Am J Respir Crit Care Med 165:690-693
10. Devuyst P. (1997). Guidelines for attribution of lung cancer to asbestos. Proceedings of an International Expert meeting on Asbestos, Asbestosis and Cancer, People and Work. Research Report. Helsinki, Finland: Finnish Institute of Occupational Health.
11. Dietmaier W, Wittwer C, Sivasubramanian N, (eds.). (2002). Rapid Cycle Real-Time PCR. Methods and Applications. Springer: Verlag.
12. Driscoll KE. (2000). TNFalpha and MIP-2: role in particle-induced inflammation and regulation by oxidative stress. Toxicol Lett 112-113:177-183
13. Flego V, Radojcic Badovinac A, Bulat-Kardum L, Matanic D, Crnic-Martinovic M, Kapovic M, Ristic S. (2009). Primary lung cancer and TNF-alpha gene polymorphisms: a case-control study in a Croatian population. Med Sci Monit 15:CR361-5.
14. Gharaee-Kermani M, Phan SH. (2005). Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. Curr Pharm Dis 11:3943-3971
15. Guo W, Wang N, Li Y, Zhang JH. (2005). Polymorphisms in tumor necrosis factor genes and susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high incidence region of North China. Chin Med J (Engl) 118:1870-1878 (Pubitemid 41748746)
16. Hering KG, Jacobsen M, Bosch-Galetke E, Elliehausen HJ, Hieckel HG, Hofmann-Preiss K, Jacques W, Jeremie U, Kotschy-Lang N, Kraus T, Menze B, Raab W, Raithel HJ, Schneider WD, Strassburger K, Tuengerthal S, Woitowitz HJ. (2003). [Further development of the International Pneumoconiosis Classification - from ILO 1980 to ILO 2000 and to ILO 2000/German Federal Republic version]. Pneumologie 57:576-584 (Pubitemid 37346648)
17. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ, Poirier O, Cambien F. (1998). Polymorphisms of the tumour necrosis factor-alpha gene coronary heart disease and obesity. Eur J Clin Invest 28:59-66.
18. Hollegaard MV, Bidwell JL. (2006). Cytokine gene polymorphism in human disease: on-line databases Supplement 3. Genes Immun 7:269-276
19. Huang SL, Su CH, Chang SC. (1997). Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 156:1436-1439
20. Huaux F, Arras M, Vink A, Renauld JC, Lison D. (1999). Soluble tumor necrosis factor (TNF). receptors p55 and p75 and interleukin-10 downregulate TNF-alpha activity during the lung response to silica particles in NMRI mice. Am J Respir Cell Mol Biol 21: 137-145
21. Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, Kim MS, Paik KH. (2001). The-238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 166:41-46
22. Kamp DW. (2009). Asbestos-induced lung diseases: an update. Transl Res 153:143-152
23. Kolb M, Schmidt M. (2003). [The role of cytokines and growth factors in fibroproliferative lung disease]. Pneumologie 57:91-97
24. Kuwano K, Hagimoto N, Hara N. (2001). Molecular mechanisms of pulmonary fibrosis and current treatment. Curr Mol Med 1:551-573
25. Liu CJ, Wong YK, Chang KW, Chang HC, Liu HF, Lee YJ. (2005). Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma. J Oral Pathol Med 34:608-612
26. Liu J, Y, Brass D, M, Hoyle G, W &Brody A. R. (1998). TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am J Pathol 153 1839-1847
27. Liu JY, Brody AR. (2001). Increased TGF-beta1 in the lungs of asbestosexposed rats and mice: reduced expression in TNF-alpha receptor knockout mice. J Environ Pathol Toxicol Oncol 20:97-108.
28. Manning CB, Vallyathan V, Mossman BT. (2002). Diseases caused by asbestos: mechanisms of injury and disease development. Int Immunopharmacol 2:191-200. (Pubitemid 34075410)
29. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul J, L, Riche F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut JF. (1999). Association of TNF2 a TNF-alpha promoter polymorphism with septic shock susceptibility and mortality: a multicenter study. JAMA 282:561-568
30. Oh BR, Sasaki M, Perinchery G, Ryu SB, Park YI, Carroll P, Dahiya R. (2000). Frequent genotype changes at-308 and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer. J Urol 163:1584-1587
31. Parker J. (1997). Radiological criteria: the use of chest imaging techniques in asbestos-related diseases. Proceedings of an International Expert meeting on Asbestos Asbestosis and Cancer People and Work. Research Report. Helsinki, Finland: Finnish Institute of Occupational Health.
32. Riha RL, Yang IA, Rabnott GC, Tunnicliffe AM, Fong KM, Zimmerman PV. (2004). Cytokine gene polymorphisms in idiopathic pulmonary fibrosis. Intern Med J 34:126-129
33. Sanceau J, Wijdenes J, Revel M, Wietzerbin J. (1991). IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factoralpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma. J Immunol 147:2630-2637
34. Sasaki M, Nakajima K, Perinchery G, Fujino T, Oh BR, Fujimoto S, Dahiya R. (2000). Frequent genotype changes at-308 of the human tumor necrosis factor-alpha promoter region in human uterine endometrial cancer. Oncol Rep 7:369-373
35. Schneider J, Arhelger R, Hauser-Heidt G. (2006). Wertigkeit der statischen Compliance-Messung bei Asbestfaserstaub-verursachten Erkrankungen der Lunge und der Pleura. Wissenschaftlicher Abschlußbericht Hauptuerband der gesterblichen berufsgenossinschaften St Augustin, 1-79.
36. Seifart C, Plagens A, Dempfle A, Clostermann U, Vogelmeier C, von Wichert P, Seifart U. (2005). TNF-alpha TNF-beta IL-6 and IL-10 polymorphisms in patients with lung cancer. Dis Markers 21:157-165
37. Shih CM, Lee YL, Chiou HL, Chen W, Chang GC, Chou MC, Lin LY. (2006). Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer 52:15-20.
38. Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, De Sanjose S, Hughes AM, Cerhan JR, Skibola DR, Purdue M, Kane E and others. (2010). Tumor necrosis factor (TNF) and lymphotoxinalpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 171:267-276
39. Sullivan DE, Ferris M, Pociask D, Brody AR. (2008). The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo. J Immunotoxicol 5:145-149
40. Szlosarek P, Charles KA, Balkwill FR. (2006). Tumour necrosis factoralpha as a tumour promoter. Eur J Cancer 42:745-750
41. Travis WD. (2004). Tumours of the lung pleura thymus and heart. Lyon: IARC.
42. Wang DJ, Yang YL, Xia QJ, Lan YJ, Wang MZ, Zhang XQ, Han JP, Zhu QS, Sun M. (2005a). [On the association of tumor necrosis factor-alpha gene polymorphisms with the susceptibility to silicosis]. Sichuan Da Xue Xue Bao Yi Xue Ban 36:679-82, 712.
43. Wang XT, Ohtsuka Y, Kimura K, Muroi M, Ishida T, Saito J, Munakata M. (2005b). Antithetical effect of tumor necrosis factor-alphagene polymorphism on coal workers' pneumoconiosis (CWP). Am J Ind Med 48:24-29
44. Whyte M, Hubbard R, Meliconi R, Whidborne M, Eaton V, Bingle C, Timms J, Duff G, Facchini A, Pacilli A, Fabbri M, Hall I, Britton J, Johnston I, Di Giovine F. (2000). Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med 162:755-758
45. Wilson AG, Di Giovine FS, Blakemore AI, Duff GW. (1992). Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1:353.
46. Wilson AG, Symons JA, Mcdowell TL, Mcdevitt HO, Duff GW. (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195-3199
47. Witte JS, Palmer LJ, O'connor RD, Hopkins PJ, Hall JM. (2002). Relation between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma. Eur J Hum Genet 10:82-85
48. Yang H, Bocchetta M, Kroczynska B, Elmishad AG, Chen Y, Liu Z, Bubici C, Mossman BT, Pass HI, Testa JR, Franzoso G, Carbone M. (2006). TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci U S A 103:10397-10402
49. Yucesoy B, Vallyathan V, Landsittel DP, Sharp DS, Weston A, Burleson GR, Simeonova P, Mckinstry M, Luster MI. (2001). Association of tumor necrosis factor-alpha and interleukin-1 gene polymorphisms with silicosis. Toxicol Appl Pharmacol 172: 75-82.
50. Yucesoy B, Vallyathan V, Landsittel DP, Simeonova P, Luster MI. (2002). Cytokine polymorphisms in silicosis and other pneumoconioses. Mol Cell Biochem 234-235:219-224
51. Zhai R, Jetten M, Schins RP, Franssen H, Borm PJ. (1998). Polymorphisms in the promoter of the tumor necrosis factoralpha gene in coal miners. Am J Ind Med 34:318-324